|
Volumn , Issue 28, 2001, Pages 50-54
|
Papillomavirus-like particle vaccines.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
CAPSID PROTEIN;
CHEMOKINE RECEPTOR CCR5;
HYBRID PROTEIN;
L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16;
ONCOPROTEIN;
PAPILLOMA VIRUS VACCINE;
SUBUNIT VACCINE;
VIRUS ANTIBODY;
VIRUS RECEPTOR;
VIRUS VACCINE;
ANIMAL;
BIOSYNTHESIS;
CLINICAL TRIAL;
CYTOTOXICITY;
FEMALE;
GENETIC TRANSFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNIZATION;
IMMUNOLOGY;
MALE;
MOUSE;
PAPILLOMA VIRUS;
RABBIT;
REVIEW;
SEXUALLY TRANSMITTED DISEASE;
ULTRASTRUCTURE;
VIRION;
VIRUS INFECTION;
ANIMALS;
ANTIBODIES, VIRAL;
AUTOANTIBODIES;
CAPSID PROTEINS;
CLINICAL TRIALS;
CYTOTOXICITY, IMMUNOLOGIC;
FEMALE;
HIV INFECTIONS;
HUMANS;
IMMUNIZATION;
MALE;
MICE;
ONCOGENE PROTEINS, VIRAL;
PAPILLOMAVIRIDAE;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
RABBITS;
RECEPTORS, CCR5;
RECEPTORS, HIV;
RECOMBINANT FUSION PROTEINS;
SEXUALLY TRANSMITTED DISEASES, VIRAL;
TRANSFECTION;
TUMOR VIRUS INFECTIONS;
VACCINES, SUBUNIT;
VIRAL VACCINES;
VIRION;
|
EID: 0001888357
PISSN: 10526773
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (78)
|
References (31)
|